Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of KRP-209 in Subjective Tinnitus
jRCT2080222932Phase 2
- Sponsor
- Kyorin Pharmaceutical
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tinnitus comparing KRP-209 with Placebo (2 arms).
02
Drugs
neramexane
03
Conditions
tinnitus
Beyond the preview
Go deeper on jRCT2080222932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222932.